Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Lack of Clustering of SCD Complications Into Two Distinct Subphenotypes In An Adult Patient Population.

Jigarkumar Parikh, MD, Thomas Kochaparambil, MD, Hongyan Xu, PhD, Betsy Clair, Kavita Natarajan, Celalettin Ustun, MD, Abdullah Kutlar, MD

Blood (2010) 116 (21): 1643.

https://doi.org/10.1182/blood.V116.21.1643.1643

Published: 2010

Journal Articles

The Quest for Hb Questembert: A Challenging Case of An Unstable Hb Variant

Kavita Natarajan, Niren Patel, MBBS, Lina Zhuang, MD, Harris Carmichael, Elizabeth Manaloor, MD, Abdullah Kutlar, MD, Ferdane Kutlar, MD

Blood (2010) 116 (21): 4814.

https://doi.org/10.1182/blood.V116.21.4814.4814

Published: 2010

Journal Articles

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang, Warren Fiskus, Daniel G. Chong, Kathleen M. Buckley, Kavita Natarajan, Rekha Rao, Atul Joshi, Ramesh Balusu, Sanjay Koul, Jianguang Chen, Andrew Savoie, Celalettin Ustun, Anand P. Jillella, Peter Atadja, Ross L. Levine, Kapil N. Bhalla

Blood (2009) 114 (24): 5024–5033.

https://doi.org/10.1182/blood-2009-05-222133

Published: 2009

Includes: Supplemental data

Journal Articles

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

Tom E. Howard, MD, PhD, Shelley A. Cole, PhD, Carol K. Kasper, MD, Afshin Ameri, MD, Kavita Natarajan, MD, Raymond G. Watts, MD, Valrie A. Manard, RN, Shelley M. Nakaya, Christine L Kempton, MD, MSc, Martina Kennedy, DO, Benjamin Kim, MD, Rathi V. Iyer, MD, Laura Almasy, PhD

Blood (2009) 114 (22): 1301.

https://doi.org/10.1182/blood.V114.22.1301.1301

Published: 2009

Journal Articles

LBH589 (panobinostat): A Potential Novel Anti-Switching Therapy.

Abdullah Kutlar, MD, Niren Patel, MBBS, Celalettin Ustun, MD, Kavita Natarajan, MBBS, Anand Jillella, MD, Betsy Clair, Ferdane Kutlar, Rosemary Chandler, BSN, RN, OCN, Steffen E. Meiler, MD, Kapil N. Bhalla, MD

Blood (2009) 114 (22): 2568.

https://doi.org/10.1182/blood.V114.22.2568.2568

Published: 2009

Journal Articles

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism

Jianguang Chen, Warren Fiskus, Kelly Eaton, Pravina Fernandez, Yongchao Wang, Rekha Rao, Pearl Lee, Rajeshree Joshi, Yonghua Yang, Ravindra Kolhe, Ramesh Balusu, Prasanthi Chappa, Kavita Natarajan, Anand Jillella, Peter Atadja, Kapil N. Bhalla

Blood (2009) 113 (17): 4038–4048.

https://doi.org/10.1182/blood-2008-08-176024

Published: 2009

Includes: Supplemental data

Journal Articles

In Vitro Exploratory Studies of Haptoglobin Polymorphisms and Their Effect on Cytokine Release from Cultured Mononuclear Cells in Sickle Cell Disease.

Komal Bora, Kavita Natarajan, MBBS, Ferdane Kutlar, MD, Hanfang Zhang, MD, PhD, Hongyan Xu, PhD, Betsy Clair, Kathleen M McKie, MD, Abdullah Kutlar, MD

Blood (2008) 112 (11): 1441.

https://doi.org/10.1182/blood.V112.11.1441.1441

Published: 2008

Journal Articles

Co-Treatment with JAK2 Inhibitor TG101209 and Panobinostat or hsp90 Inhibitor AUY922 Attenuates Mutant JAK2-V617F Levels and Activity in Human Myeloproliferative Disorder Cells

Yongchao Wang, Warren Fiskus, Kavita Natarajan, Anand Jillella, Cornelia Quadt, Peter Ataja, Ross Levine, Kapil N. Bhalla

Blood (2008) 112 (11): 3739.

https://doi.org/10.1182/blood.V112.11.3739.3739

Published: 2008

Journal Articles

Heat Shock Protein Inhibition in Sickle Cell Disease: A Novel Approach to Attenuating the Inflammatory Response?.

Kavita Natarajan, MBBS, John Catravas, PhD, Joseph Cannon, PhD, Tao Li, MD, Ferdane Kutlar, MD, Gloria Sloan, Sabine Fields, RN, Betsy Clair, Abdullah Kutlar, MD

Blood (2007) 110 (11): 2263.

https://doi.org/10.1182/blood.V110.11.2263.2263

Published: 2007

Journal Articles

A Case of HPP with a Novel Combination of α and β Spectrin Mutations.

Kavita Natarajan, MBBS, Ferdane Kutlar, MD, Tao Li, MD, Patrick Gallagher, MD, Abdullah Kutlar, MD

Blood (2007) 110 (11): 1736.

https://doi.org/10.1182/blood.V110.11.1736.1736

Published: 2007

Journal Articles

Spleen Related Complications and Implications of Splenectomy in Patients with Hemoglobin SC Disease.

Karthi Subbannan, MD, Celalettin Ustun, MD, Kavita Natarajan, MBBS, Betsy Clair, Abdullah Kutlar, MD

Blood (2007) 110 (11): 3798.

https://doi.org/10.1182/blood.V110.11.3798.3798

Published: 2007

Journal Articles

Up-Front Therapy for Multiple Myeloma: A Survey of Practice Patterns in the USA.

Kavita Natarajan, MD, Gary H. Lyman, MD, Oscar F. Ballester, MD

Blood (2005) 106 (11): 5172.

https://doi.org/10.1182/blood.V106.11.5172.5172

Published: 2005

NARROW

Lack of Clustering of SCD Complications Into Two Distinct Subphenotypes In An Adult Patient Population.

The Quest for Hb Questembert: A Challenging Case of An Unstable Hb Variant

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

LBH589 (panobinostat): A Potential Novel Anti-Switching Therapy.

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism

In Vitro Exploratory Studies of Haptoglobin Polymorphisms and Their Effect on Cytokine Release from Cultured Mononuclear Cells in Sickle Cell Disease.

Co-Treatment with JAK2 Inhibitor TG101209 and Panobinostat or hsp90 Inhibitor AUY922 Attenuates Mutant JAK2-V617F Levels and Activity in Human Myeloproliferative Disorder Cells

Heat Shock Protein Inhibition in Sickle Cell Disease: A Novel Approach to Attenuating the Inflammatory Response?.

A Case of HPP with a Novel Combination of α and β Spectrin Mutations.

Spleen Related Complications and Implications of Splenectomy in Patients with Hemoglobin SC Disease.

Up-Front Therapy for Multiple Myeloma: A Survey of Practice Patterns in the USA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only